X-PACT Immunolight (Breast Cancer, Head & Neck Cancer, Melanoma, and Sarcoma) - Clinical Trial

Email to Participate

What is the Purpose of this Study?

We are doing this study to find out if an experimental drug and device system called X-PACT is a safe and effective treatment for various forms of cancer.

What is the Condition Being Studied?

Sarcoma, Breast Cancer, Melanoma, and Head & Neck Cancer

Who Can Participate in the Study?

Adults ages 18+ who:

Have soft tissue sarcoma, melanoma, breast cancer, or head and neck cancer
Still have cancer after treatment with the standard therapies
Do not have any other treatment options left

For more information about who can join this study, please contact the study team at elizabeth.sachs@duke.edu

Age Group

Adults

What is Involved?

If you join this study, you will:

Be injected with the study treatment (X-PACT) five times
Give tumor tissue
Have physical exams, blood draws, and urine tests
Have a heart scan (ECG)
Have imaging scans (X-Rays, MRI and/or CT)

Please visit https://www.immunolight.com/patients to learn more about the study treatment.

Study Details

Full Title

Phase 1 Study of X-PACT (X-ray Psoralen Activated Cancer Therapy) for Intra-tumoral Injection in Patients with Advanced Head and Neck Cancer, Breast Cancer, Soft Tissue Sarcoma or Melanoma

Principal Investigator